Medical University of Vienna-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2022

  1. Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia

    Pregnancy Hypertension, Vol. 27, pp. 42-50

2021

  1. Role of prenatal magnetic resonance imaging in fetuses with isolated anomalies of corpus callosum: multinational study

    Ultrasound in Obstetrics and Gynecology, Vol. 58, Núm. 1, pp. 26-33

2016

  1. Extending the scope of pooled analyses of individual patient biomarker data from heterogeneous laboratory platforms and cohorts using merging algorithms

    Pregnancy Hypertension, Vol. 6, Núm. 1, pp. 53-59

2014

  1. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia

    Hypertension, Vol. 63, Núm. 2, pp. 346-352

2012

  1. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients

    American Journal of Obstetrics and Gynecology, Vol. 206, Núm. 1, pp. 58.e1-58.e8

2010

  1. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia

    American Journal of Obstetrics and Gynecology, Vol. 202, Núm. 2, pp. 161.e1-161.e11